Form D · Other Technology
Twenty30 Health, Inc.
Philadelphia, PA · CIK 0001994682
Offering snapshot reported Oct 15, 2024 · SEC filing
- Reported sold
- $1.88M Offering amount: $1.88M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 7, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2024 | Initial | $1,878,889 | No comparison | 5 | SEC filing |
| Sep 27, 2023 | Initial | $5,190,000 | No comparison | 9 | SEC filing |
| Sep 27, 2023 | Initial | $1,325,025 | No comparison | 29 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-526855
Source: Form D, filed Oct 15, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rajesh Aggarwal | Director, Executive |
| Jesse Ai | Director |
| Lenore Champagne Beirne | Director |
| Stephen K. Klasko | Director |
| Krishnan Sridharan | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
2400 Market Street Suite 269
Philadelphia, PA, 19103
Philadelphia, PA, 19103